Programme SOM0044 for Parkinson’s Disease
SOM0044 is a small molecule for the treatment of Parkinson’s disease.
CytoDyn plans for Phase II basket trial of leronlimab
CytoDyn’s Phase II basket trial will involve 30 patients with locally advanced or metastatic solid tumours. Credit: Colin Behrens from Pixabay.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
Jeeva Informatics Solutions
Jeeva Informatics Solutions (Jeeva) is a seed-stage start-up on a...
About
Jeeva Informatics Solutions (Jeeva) is a seed-stage start-up on a mission to develop artificial intelligence (AI)-driven decentralised clinical trials and optimise patient-focused clinical research.
FollowMake an Enquiry
-
SOM Biotech
SOM Biotech is an Artificial Intelligence AI drug discovery and...
About
SOM Biotech is an Artificial Intelligence AI drug discovery and development company focused on the development of therapies for orphan indications through the proprietary AI-based drug discovery technology.
FollowMake an Enquiry
-
Pilloxa
Pilloxa creates digital and remote solutions to optimise clinical trials...
About
Pilloxa creates digital and remote solutions to optimise clinical trials and patient support programmes through supporting medical adherence and patient retention.
FollowMake an Enquiry